BL-B01D1
Product Specifications
Target
Antibody-Drug Conjugates (ADCs) |||EGFR
Related Pathways
Angiogenesis|||JAK/STAT signaling|||Antibody-drug Conjugate/ADC Related|||Tyrosine Kinase/Adaptors
Bioactivity
BL-B01D1 is a bispecific ADC that targets EGFR and HER3 via the bispecific antibody Izalontamab. It exerts cytotoxic effects on various cancer cells by using its ADC toxin ED04 to inhibit DNA replication and synthesis.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
